F O Finkelstein

1.1k total citations
21 papers, 767 citations indexed

About

F O Finkelstein is a scholar working on Nephrology, Surgery and Hematology. According to data from OpenAlex, F O Finkelstein has authored 21 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 4 papers in Surgery and 3 papers in Hematology. Recurrent topics in F O Finkelstein's work include Dialysis and Renal Disease Management (13 papers), Muscle and Compartmental Disorders (2 papers) and Iron Metabolism and Disorders (2 papers). F O Finkelstein is often cited by papers focused on Dialysis and Renal Disease Management (13 papers), Muscle and Compartmental Disorders (2 papers) and Iron Metabolism and Disorders (2 papers). F O Finkelstein collaborates with scholars based in United States, Iran and Pakistan. F O Finkelstein's co-authors include Alan S. Kliger, Laura Troidle, Nancy Gorban‐Brennan, Diane Wuerth, Susan H. Finkelstein, C. P. Bastl, P Juergensen, R S Sherwin, Philip Felig and Rosa Hendler and has published in prestigious journals such as Journal of Clinical Investigation, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

F O Finkelstein

21 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F O Finkelstein United States 15 459 170 128 117 105 21 767
CA Jones United States 3 570 1.2× 115 0.7× 120 0.9× 44 0.4× 34 0.3× 9 759
Rathika Krishnasamy Australia 18 505 1.1× 114 0.7× 139 1.1× 30 0.3× 43 0.4× 56 924
Filitsa Bender United States 15 464 1.0× 249 1.5× 148 1.2× 46 0.4× 42 0.4× 37 871
Charles J. Foulks United States 16 389 0.8× 219 1.3× 134 1.0× 59 0.5× 36 0.3× 35 731
Jianxiong Lin China 16 516 1.1× 105 0.6× 142 1.1× 42 0.4× 34 0.3× 60 766
Belkacem Issad France 16 485 1.1× 194 1.1× 158 1.2× 22 0.2× 48 0.5× 42 660
Chunyan Yi China 18 626 1.4× 168 1.0× 180 1.4× 37 0.3× 47 0.4× 64 858
Maristela Böhlke Brazil 15 465 1.0× 120 0.7× 192 1.5× 45 0.4× 17 0.2× 40 713
W E Bloembergen United States 9 596 1.3× 241 1.4× 188 1.5× 19 0.2× 48 0.5× 10 818
Marjorie Foo Singapore 13 369 0.8× 47 0.3× 42 0.3× 75 0.6× 19 0.2× 39 716

Countries citing papers authored by F O Finkelstein

Since Specialization
Citations

This map shows the geographic impact of F O Finkelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F O Finkelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F O Finkelstein more than expected).

Fields of papers citing papers by F O Finkelstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F O Finkelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F O Finkelstein. The network helps show where F O Finkelstein may publish in the future.

Co-authorship network of co-authors of F O Finkelstein

This figure shows the co-authorship network connecting the top 25 collaborators of F O Finkelstein. A scholar is included among the top collaborators of F O Finkelstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F O Finkelstein. F O Finkelstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johansen, Kirsten L., F O Finkelstein, Dennis A. Revicki, et al.. (2011). Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients. Nephrology Dialysis Transplantation. 27(6). 2418–2425. 65 indexed citations
2.
Martin, Mona L., Donald L. Patrick, Shravanthi R. Gandra, et al.. (2010). Content validation of two SF-36 subscales for use in type 2 diabetes and non-dialysis chronic kidney disease-related anemia. Quality of Life Research. 20(6). 889–901. 17 indexed citations
3.
Troidle, Laura & F O Finkelstein. (2008). Catheter-Related Bacteremia in Hemodialysis Patients: The Role of the Central Venous Catheter in Prevention and Therapy. The International Journal of Artificial Organs. 31(9). 827–833. 13 indexed citations
4.
Juergensen, Peter H., Jordi Eras, B. G. McClure, Alan S. Kliger, & F O Finkelstein. (2005). The Impact of Various Cycling Regimens on Phosphorus Removal in Chronic Peritoneal Dialysis Patients. The International Journal of Artificial Organs. 28(12). 1219–1223. 15 indexed citations
5.
Wuerth, Diane, et al.. (2001). Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. American Journal of Kidney Diseases. 37(5). 1011–1017. 110 indexed citations
6.
Juergensen, Peter H., et al.. (2000). Tidal peritoneal dialysis: Comparison of different tidal regimens and automated peritoneal dialysis. Kidney International. 57(6). 2603–2607. 18 indexed citations
7.
Juergensen, P, et al.. (1999). Tidal peritoneal dialysis to achieve comfort in chronic peritoneal dialysis patients.. PubMed. 15. 125–6. 17 indexed citations
8.
Troidle, Laura, Nancy Gorban‐Brennan, Alan S. Kliger, & F O Finkelstein. (1999). Once-daily intraperitoneal cefazolin and oral ciprofloxacin as empiric therapy for the treatment of peritonitis.. PubMed. 15. 213–6. 13 indexed citations
9.
Troidle, Laura, Nancy Gorban‐Brennan, Alan S. Kliger, & F O Finkelstein. (1998). Differing outcomes of gram-positive and gram-negative peritonitis. American Journal of Kidney Diseases. 32(4). 623–628. 110 indexed citations
10.
Wuerth, Diane, Susan H. Finkelstein, P Juergensen, et al.. (1997). Quality of life assessment in chronic peritoneal dialysis patients.. PubMed. 13. 125–7. 15 indexed citations
11.
Juergensen, P, Diane Wuerth, Susan H. Finkelstein, et al.. (1997). Psychosocial factors and clinical outcome on CAPD.. PubMed. 13. 121–4. 27 indexed citations
12.
Steele, Thomas E., Diane Wuerth, Susan H. Finkelstein, et al.. (1996). Sexual experience of the chronic peritoneal dialysis patient.. Journal of the American Society of Nephrology. 7(8). 1165–1168. 63 indexed citations
13.
Finkelstein, F O, Alan S. Kliger, Nancy Gorban‐Brennan, et al.. (1995). Outcome of polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. American Journal of Kidney Diseases. 25(3). 461–464. 30 indexed citations
14.
Mooraki, Ahmad, Alan S. Kliger, P Juergensen, Nancy Gorban‐Brennan, & F O Finkelstein. (1994). Selected outcome criteria and adequacy of dialysis in diabetic and elderly patients on CAPD therapy.. PubMed. 10. 89–93. 6 indexed citations
15.
Rigsby, Michael O., et al.. (1993). Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney International. 44(1). 191–198. 38 indexed citations
16.
Kliger, Alan S., et al.. (1992). Pseudomonas exit site infections in continuous ambulatory peritoneal dialysis patients.. Journal of the American Society of Nephrology. 2(10). 1498–1501. 37 indexed citations
17.
Schachter, E. Neil, F O Finkelstein, C. P. Bastl, & G.J. Walker Smith. (1977). Diagnostic problems in pulmonary-renal syndromes.. PubMed. 115(1). 155–9. 9 indexed citations
18.
Finkelstein, F O & John P. Hayslett. (1976). Nephrotic syndrome: etiology, diagnosis, and treatment.. PubMed. 31(8). 39–44, 48. 2 indexed citations
19.
Sherwin, R S, C. P. Bastl, F O Finkelstein, et al.. (1976). Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.. Journal of Clinical Investigation. 57(3). 722–731. 132 indexed citations
20.
Bastl, C. P., Ernesto D. Hendler, & F O Finkelstein. (1975). Leukocyte responses to acute renal transplant rejection.. PubMed. 4(6). 228–33. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by CA Jones Breakdown of academic impact, for papers by Rathika Krishnasamy Breakdown of academic impact, for papers by Filitsa Bender Breakdown of academic impact, for papers by Charles J. Foulks Breakdown of academic impact, for papers by Jianxiong Lin Breakdown of academic impact, for papers by Belkacem Issad Breakdown of academic impact, for papers by Chunyan Yi Breakdown of academic impact, for papers by Maristela Böhlke Breakdown of academic impact, for papers by W E Bloembergen Breakdown of academic impact, for papers by Marjorie Foo
Rankless by CCL
2026